Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Clemastine
(D03535)
[1] Clemastine[2] Clemastine fumarate ,
Clemastine (D03535) 💬
[1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 13 💬
2Clemastine fumarate
(D03535)
[1] Clemastine[2] Clemastine fumarate ,
Clemastine (D03535) 💬
[1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 13 💬
3Clemastine fumarate tablets
(D03535)
[1] Clemastine[2] Clemastine fumarate ,
Clemastine (D03535) 💬
[1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 179 💬
4Clemastine milstein 1 MG, tabletten
(D03535)
[1] Clemastine[2] Clemastine fumarate ,
Clemastine (D03535) 💬
[1] HRH1 💬 [4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 13 💬
5Metformin and clemastine IN combination
(D03535)
[1] Metformin[2] Metformin hydrochloride ,
Metformin 💬
[2] PRKAA,
PRKAA 💬
[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[1] 13 💬
6Open label clemastine with A blinded randomize withdrawal
(D03535)
----[1] 179 💬